A Phase 1 Study of 131I-CLR1404 in Patients with Relapsed or Refractory Advanced Solid Tumors: Dosimetry, Biodistribution, Pharmacokinetics, and Safety
Figure 5
Plasma pharmacokinetics of 127I-CLR1404.
The remaining fraction of 127I-CLR1404 within the plasma is plotted over time. The top graph shows each individual subject while the bottom graph shows the average of the group with the standard deviation represented with error bars.